Company Profile
OKYO Pharma Stock Price, News & Analysis
- Ticker:
- OKYO
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Stock performance
1.64 USD (0.00%)
Close
Last updated: July 28, 2026
89.2M USD
Market cap
Why the stock is moving
The latest monitored headline was “OKYO Pharma Announces Purchase of Shares by Chief Scientific Officer”. OKYO was little changed in the corresponding trading session, closing at $1.64 on Jul 28, 2026.
Company overview
Business overview
OKYO Pharma is a biotechnology company focused on inflammation, pain, and ophthalmology-related disease biology. Its programs are aimed at serious conditions where immune modulation and localized therapy matter.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, OKYO sits in specialty biotechnology.
Business Model Characteristics
The company depends on clinical data, target validation, and the ability to create a differentiated inflammation and eye-care story.
Position Within the Biotechnology Landscape
OKYO is a catalyst-sensitive specialty name whose stock is driven by early-stage progress.
Future catalysts
OKYO’s catalysts are its ophthalmic-inflammatory pipeline and any update that shows the company can still build a real eye-disease story. The company remains early and data-dependent.
Recent news
- 01
OKYO Pharma Announces Purchase of Shares by Chief Scientific Officer
Source: OKYO Pharma
- 02
OKYO Pharma to Participate in the BTIG Biotechnology Conference 2026
Source: OKYO Pharma
- 03
OKYO Pharma Announces Purchase of Shares by Director
Source: OKYO Pharma
- 04
OKYO Pharma Announces Purchase of Shares by Chief Executive Officer
Source: OKYO Pharma
- 05
OKYO Pharma Announces Purchase of Shares by Chairman
Source: OKYO Pharma
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of OKYO Pharma (OKYO)?
OKYO Pharma (OKYO) most recently closed at 1.64 USD, a 0.00% move versus the previous session.
What is the market cap of OKYO Pharma (OKYO)?
OKYO Pharma currently has a market capitalization of 89.2M USD on BioPharmSignal.
What does OKYO Pharma do?
OKYO Pharma is a biotechnology company focused on inflammation, pain, and ophthalmology-related disease biology. Its programs are aimed at serious conditions where immune modulation and localized therapy matter.
On which exchange is OKYO stock listed?
OKYO Pharma (OKYO) is associated with NASDAQ, United States, Biopharma.
What is Pharma?
OKYO Pharma is a biotechnology company focused on inflammation, pain, and ophthalmology-related disease biology.
Which conditions is OKYO Pharma targeting with Pharma?
OKYO Pharma is associated with inflammatory disease, ophthalmology based on its company overview and current catalyst commentary.
How does OKYO Pharma describe recent progress with Pharma?
OKYO’s catalysts are its ophthalmic-inflammatory pipeline and any update that shows the company can still build a real eye-disease story. The company remains early and data-dependent.
What future catalysts are investors watching for OKYO Pharma?
OKYO’s catalysts are its ophthalmic-inflammatory pipeline and any update that shows the company can still build a real eye-disease story. The company remains early and data-dependent.